Patient Questions

ONCONOMICS PLUS, which covers the sensitivity/resistance on conventional & biological/natural substances and CHEMOSNIP which covers the ability of the patients to activate the drugs and metabolize them properly.

If a patient asks for additional natural substances to be tested, we can include them in Onconomics Plus or Onconomics Extracts. If additional testing for chemotherapy drugs is required, we are able to include them in the Onconomics test.

Usually the results are available within 7 to10 working days from receipt of your sample.

On our website, under the category of R.G.C.C. Network/Personnel, you will find information about our branches and representatives. You can contact them and ask for the list of collaborative physicians. Details of our collaborative clinics are available in the same category as well.

As the biopsy is already part of the tumor, this means that all the cells are cancerous. For that reason there is no need to search for CTC populations.

The main cells of interest in analytic platform are CTCs, which are obtained by negative selection and sorting via flow cytometer (so that we will obtain viable CTCs from a blood sample). In cases like Glioblastomas cancer cells cannot be detected in a blood sample due to blood-brain-barrier and we need a tissue sample in order to be able to proceed with the test.

We have a network of R.G.C.C. collaborators and clinicians from all over the world. You will find this list on our website or by contacting R.G.C.C.’s branch offices or representatives.

The main cells of interest in analytic platform are CTCs which are obtained by negative selection and sorting via flow cytometer (so that we will obtain viable CTCs from a blood sample). Further information can be obtained through our web site.

We have collaboration with DHL, FEDEX and TNT courier.

For all solid and hematologic malignancies with exception of primary tumor of the CNS.

in one type of cancer there are several subpopulation of cancer cells but only one has the tumor initiating properties (known as cancer stem cells like) . The rest subset does not actually promote the disease progression. So this is the population that were interested to harvest and analyze and this subset exist in higher proportion in CTCs

R.G.C.C. FAQ Database